Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the stock right now. Should you?

Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group"), who collectively own approximately 5.4% of the outstanding stock of Atea Pharmaceuticals, Inc.

The Nifty Pharma index closed on a negative note on Wednesday. Shares of Mankind Pharma Ltd.(up 0.24 per cent), Biocon ...

Domestic equity benchmarks halted their seven-day upward run today as banks, financials, media, pharma and energy stocks ...

Investing.com -- AstraZeneca (NASDAQ: AZN) Plc’s Chief Executive Officer, Pascal Soriot, has warned that Europe is rapidly losing its pharmaceutical innovation edge to China. He voiced his concerns ...

WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica” or the "Company”) (Nasdaq: VRCA ...

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...

Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House ...

Avantax Advisory Services Inc. acquired a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 2,140 ...

Company Contact Ron Bentsur Chairman, Chief Executive Officer and President [email protected] Media Relations Contact Nuvectis Pharma NewsMORE Related Stocks ...